Recent news on Metoprolol Succinate

A simple reminder will do: Increasing the use of evidence-based ...  -  25 May 2007
TheHeart.Org,3.125 mg bid or metoprolol succinate 12.5 mg bid)" and recommended cardiology follow-up for patients with symptoms that put them in NYHA class 3 or 4.

Watson Enters Into Agreement to Permit Sandoz to Launch Metoprolol ...  -  May 21, 2007
PharmaLive.com (press release),Watson was awarded market exclusivity as the first generic applicant to submit an Abbreviated New Drug Application (ANDA) for metoprolol succinate

ORBUS PATENT APPLICATIONS FOR EXTENTED RELEASE METOPROLOL ...  -  May 16, 2007
Filing Services Canada (press release),..."This in house developed drug delivery technology is proving valuable for expanding the market potential of the Orbus Metoprolol Succinate as well as

Sandoz Receives FDA Approval for Generic Toprol XL(R) 50 mg Tablet  -  May 21, 2007
PR Newswire (press release),Launch plans and timing for metoprolol succinate 50 mg ER have not been finalized by Sandoz. About Sandoz Sandoz, a division of the Novartis group,

KV receives approval for generic versions of Toprol-XL  -  May 22, 2007
Pharmaceutical Business ReviewUS-based KV Pharmaceutical Company has received final approval from the FDA to market its 100mg and 200mg strengths of metoprolol succinate extended-release

KV Pharmaceutical Announces Approval for Two Strengths of Generic ...  -  May 20, 2007
ag-IP-news Agency,Additionally, the approval positions KV to eventually offer all four dosage strengths of generic metoprolol succinate extended release tablets pending

KV Pharmaceutical Updates Metoprolol Succinate Application Status  -  Mar 29, 2007
Drug Newswire (press release),...timing on its pending first-to-file application with the Food and Drug Administration for metoprolol succinate (Toprol(R) XL, marketed by AstraZeneca).

Heart Failure and Its Management With beta-Blockade: Potential ...  -  Mar 31, 2007
HeartZine,Based on published clinical trial results, bisoprolol, carvedilol, and sustained-release metoprolol succinate are recommended for systolic HF.

GSK Announces Nationwide Availability Of Once-a-day Coreg CR™ For ...  -  Mar 26, 2007
Medical News Today (press release),COMET did not compare carvedilol to metoprolol succinate (Toprol-XL®*). The efficacy of carvedilol versus metoprolol succinate in heart failure has not been

GSK Announces Nationwide Availability of Once-A-Day COREG CR(TM ...  -  Mar 23, 2007
Drug Newswire (press release),COMET did not compare carvedilol to metoprolol succinate (Toprol-XL(R)). The efficacy of carvedilol versus metoprolol succinate in heart failure has not

ORBUS PHARMA INC. ANNOUNCES SUCCESFUL BIOEQUIVALENCE RESULTS FOR ITS  -  Feb 26, 2007
Filing Services Canada (press release),Metoprolol succinate is the world's leading cardioselective beta-blocker for hypertension, angina pectoris, heart failure, disturbances of cardiac rhythm

Metoprolol useful in pediatric hypertension  -  Mar 2, 2007
Therapeutics Daily (subscription) (press release),NEW YORK (Reuters Health) - Extended release metoprolol succinate appears to be appropriate antihypertensive therapy in children, researchers report in the

Orbus Pharma Inc. Reports 2006 Results (All amounts in thousands ...  -  Mar 16, 2007
Filing Services Canada (press release),...states) in its European drug development for the 190mg tablet of a once per day formulation for metoprolol succinate extended release ("XR") tablets.

QuitPak enters pilot study  -  Feb 13, 2007
In-PharmaTechnologist.com,...that has demonstrated in vitro equivalency with AstraZeneca's Toprol XL (metoprolol succinate) in the US and Beloc-ZOK (metoprolol tartrate) in Europe.

KV Pharmaceutical Reports Preliminary Record Revenues for Fiscal ...  -  Feb 7, 2007
Earthtimes.orgTo that end, we are awaiting approval, yet this fiscal year, of our multiple strength applications for Metoprolol Succinate (Toprol-XL(R) - AstraZeneca),

Par Pharmaceutical begins shipment of generic Toprol-XL  -  Dec 22, 2006
Therapeutics Daily (subscription) (press release),Par began shipping metoprolol succinate extended release 25 mg tablets. Toprol-XL is a beta1-selective (cardioselective) adrenoceptor-blocking agent,

Par Pharmaceutical begins shipment of generic Toprol-XL  -  Dec 22, 2006
Therapeutics Daily (subscription) (press release),Par began shipping metoprolol succinate extended release 25 mg tablets. Toprol-XL is a beta1-selective (cardioselective) adrenoceptor-blocking agent,

AstraZeneca Announces New Program that Offers Significant and ...  09 Nov 2006
...products, including NEXIUM® (esomeprazole), CRESTOR® (rosuvastatin), SEROQUEL® (quetiapine fumarate), TOPROL XL® (metoprolol succinate) and ARIMIDEX ... -Yahoo! News (press release) Orbus Pharma Inc. Reports Third Quarter 2006 Results  Nov 6, 2006
...of the second phase of the bioequivalence studies in its European drug development of a once per day formulation for metoprolol succinate 190mg extended ... -CCNMatthews (press release), KV Clarifies Citizen Petition Filed With FDA  Oct 24, 2006
...& Kenyon, filed a Citizen Petition pertaining to generic equivalents of the 100mg and 200mg strengths of Toprol XL(R) (metoprolol succinate extended-release ... -Drug Newswire (press release), KV Pharmaceutical Issue Clarification On Citizen's Petition ...  Oct 20, 2006
...said the Citizen Petition was filed by its own counsel, Kenyon & Kenyon, related to generic equivalents of Toprol XL, metoprolol succinate extended-release ... -Trading Markets, Orbus Pharma Inc. Announces Further Successful Bioequivalence ...  Sep 7, 2006
...of the second phase of the bioequivalence studies in its European drug development of a once per day formulation for metoprolol succinate 190mg extended ... -CCNMatthews

Caregiving teaches writer much  Sep 5, 2006
...prazosin hydrochloride? Did you split the metoprolol succinate in half?" These were daily questions. Grandma's death came suddenly. My ... -Hattiesburg American

Par Pharmaceutical Begins Shipment of Generic TOPROL-XL(R)  -  Nov 21, 2006
PR Newswire (press release),Par began shipping metoprolol succinate extended release 25 mg tablets today. TOPROL-XL is a beta1-selective (cardioselective) adrenoceptor-blocking agent,

Par Pharmaceutical Begins Shipment of Generic Toprol-XL  -  Nov 22, 2006
PharmaLive.com (press release),Metoprolol succinate extended release is indicated for the treatment of hypertension, alone or in combination with other antihypertensives; the long- term

AstraZeneca signs distribution agreement with Par Pharmaceutical ...  -  Nov 22, 2006
WebWire (press release),The signing of this agreement does not affect the availability of AstraZeneca’s branded version of metoprolol succinate, TOPROL-XL.

AstraZeneca Announces Distribution Agreement With Par ...  -  Nov 22, 2006
PharmaLive.com (press release),This agreement does not affect the availability of AstraZeneca's branded version of metoprolol succinate, TOPROL-XL(R). AstraZeneca will continue to

AstraZeneca Says Par Pharma To Distribute Generic Version Of ...  -  Nov 22, 2006
Trading Markets,The metoprolol succinate extended release tablets is a substitute for AstraZeneca's TOPROL-XL extended release tablets. The Woodcliff Lake, New Jersey-based

AstraZeneca sees FY EPS outlook at lower-end of 3.85-3.95 usd ...  -  Nov 22, 2006
Forbes,It said the agreement would not affect the availability of its branded version of metoprolol succinate, Toprol-XL, and will continue to manufacture and make

Par Pharma in AstraZeneca Pact  -  Nov 22, 2006
TheStreet.comThe New Jersey-based company began shipping metoprolol succinate extended release 25 mg tablets Tuesday. TOPROL-XL is a beta1-selective (cardioselective)

AstraZeneca in authorized generic deal with Par  -  Nov 21, 2006
ReutersVX: Quote, Profile, Research) began selling a version of Toprol-XL, known generically as metoprolol succinate. The 25 mg dose accounts for an estimated 20

AstraZeneca Approves Generic Toprol-XL, Cuts Forecast (Update1)  -  Nov 21, 2006
BloombergThe move may help Toprol-XL compete with cheaper generic versions of metoprolol succinate. Yesterday Novartis AG, the world's second-largest maker of

AstraZeneca at low end after generic launch  -  Nov 22, 2006
MoneyWeek (Subscription),Astra said that a 25 mg version of metoprolol succinate was launched in the US yesterday by Eon Labs, part of Sandoz. The 25 mg dose accounts for an

AstraZeneca sees FY EPS outlook at lower end  -  Nov 22, 2006
Hemscott,AstraZeneca said the agreement would not affect the availability of its branded version of metoprolol succinate, TOPROL-XL, and will continue to manufacture

AstraZeneca sees FY EPS at lower-end of 3.85-3.95 usd guidance UPDATE  -  Nov 22, 2006
Euro2day,It said the agreement would not affect the availability of its branded version of metoprolol succinate, TOPROL-XL, and will continue to manufacture and make

AstraZeneca sees FY EPS at lower-end of 3.85-3.95 usd guidance  -  Nov 22, 2006
Life Style Extra,...metoprolol succinate in the United States. Currently, the authorized generic. product will be distributed in the 25 mg dosage strength. The signing of this

Par Pharma launches generic Toprol  -  Nov 21, 2006
BusinessWeekThe agreement covers 25-milligram strength metoprolol succinate extended release tablets. Another generic drug developer, Eon Labs launched its own

AstraZeneca in authorized generic deal with Par  -  Nov 22, 2006
Therapeutics Daily (subscription) (press release),The move comes a day after a generic unit of Novartis AG began selling a version of Toprol-XL, known generically as metoprolol succinate.

Par, AstraZ sign deal on generic Toprol  -  Nov 24, 2006
United Press InternationalPar said the supply and distribution agreement with AstraZeneca gives AstraZeneca the distribution rights to the metoprolol succinate extended-release

First-Time Generic Approvals: Climara, Toprol XL, Effexor  Aug 11, 2006
...system for the treatment of menopausal symptoms and hypoestrogenism, and the prevention of postmenopausal osteoporosis; metoprolol succinate extended-release ... -Medscape (subscription)

DJ UPDATE:MARKET COMMENT: European Stocks End Higher  Aug 2, 2006
...protecting its heart drug Toprol X after the Food and Drug Administration granted approval to Novartis' Sandoz for 25 mg of metoprolol succinate, a generic ... -Wiadomosci onet.pl

DJ MARKET COMMENT: London Stocks End Higher  Aug 2, 2006
...protecting its heart drug Toprol XL after the US Food & Drug Administration granted approval to Novartis' Sandoz for 25 mg of metoprolol succinate, a generic ... -Wiadomosci onet.pl

KV Pharmaceutical Company Reports Fiscal 2007 First Quarter ...  Aug 8, 2006
...which are expected to provide the catalyst for continued revenue growth, particularly the significant opportunity represented by metoprolol succinate (Toprol XL ... -Yahoo! News

Orbus Pharma Inc. Reports Second Quarter 2006 Results  Aug 9, 2006
...the most demanding phase of the bioequivalence studies in its European drug development of a once per day formulation for metoprolol succinate extended release ... -CCNMatthews

AstraZeneca Says Has Full Confidence In Toprol XL Patents  Aug 2, 2006
It made the statement after the US Food & Drug Administration granted approval to Novartis' (NVS) Sandoz for 25 mg of metoprolol succinate, a generic form of ... -Easy Bourse (Communiqués de presse)

Abbott Gets Oscient Drug Canada License and AstraZeneca Says Has ...  Aug 11, 2006
It made the statement after the US Food & Drug Administration granted approval to Novartis' Sandoz for 25 mg of metoprolol succinate, a generic form of Toprol ... -Financial News USA

Treating heart failure  Jul 8, 2006
These include carvedilol, bisoprolol, metoprolol succinate (the last one is a once daily drug which is not available in Malaysia; the available metoprolol ... -Malaysia Star



Toprol XL uncertainty weighs heavy on AstraZeneca  Feb 3, 2006
But loss of a crucial patent infringement lawsuit for Toprol XL (metoprolol succinate) in the USA last month is giving AstraZeneca investors the jitters, and ... - Pharma Times (subscription),

TOPROL-XL® (metoprolol succinate): AstraZeneca to appeal decision ...  Jan 18, 2006
...decision of Judge Rodney Sippel of the US District Court for the Eastern District of Missouri in litigation titled In Re Metoprolol Succinate Patent Litigation ... - Biotech Intelligence

KV Pharmaceutical Reports Record Revenues for Fiscal 2006 Third ...  Feb 7, 2006
AstraZeneca based on the Company's submission of ANDAs seeking approval to market generic formulations of Toprol-XL(R) (metoprolol succinate extended-release ... - PR Newswire

Generics Erosion will Result in Slow Growth of Market to Treat ...  Feb 1, 2006
...should spur near- term increased sales of carvedilol, GlaxoSmithKline's Coreg and Roche's Dilatrend, as well as metoprolol succinate, AstraZeneca's Toprol XL. ... - PR Newswire

Toprol XL uncertainty weighs heavy on AstraZeneca  Feb 3, 2006
But loss of a crucial patent infringement lawsuit for Toprol XL (metoprolol succinate) in the USA last month is giving AstraZeneca investors the jitters, and ... - Pharma Times (subscription)

Andrx Granted Summary Judgment for Generic Toprol-XL  Jan 18, 2006
...with respect to each company's abbreviated new drug applications (ANDA) for the generic version of Toprol-XL(R) (metoprolol succinate extended-release tablets ... - Genetic Engineering News

AstraZeneca’s patents on Toprol-XL invalidated  Jan 18, 2006
AstraZeneca said its patents on Toprol-XL extended release tablets, known generically as metoprolol succinate, were due to expire on Sept. 17 next year. ... - philly.com

AstraZeneca loses exclusive rights to drug  Jan 19, 2006
Toprol-XL extended release tablets, known generically as metoprolol succinate, is AstraZeneca's third-best-selling blockbuster, behind Nexium for heartburn and ... - philly.com

KV Pharmaceutical Company Wins Summary Judgment in Patent ...  Jan 18, 2006
...by AstraZeneca based on the Company's submission of ANDAs seeking approval to market generic formulations of Toprol-XL® (metoprolol succinate extended-release ... - Yahoo! News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional